TrialClinical and translational science2022

An evaluation of a supratherapeutic dose of inclisiran on cardiac repolarization in healthy volunteers: A phase I, randomized study.

David Kallend et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.